Background: Childhood cancer represents an important health problem in Basrah with an incidence rate as high as rates in western countries. Little is known about the prognosis and survival of children diagnosed with malignancy after initiation of treatment. Objectives: to estimate the one-year survival of children diagnosed with malignant diseases in Basrah and to identify non-medical risk factors for the risk of death during the first year following diagnosis. Methods: This is a hospital-based follow up study of 352 children aged less than 15 years diagnosed with any sort of malignant disease. The study was conducted in Basrah Specialized Hospital for Children over the period (1 st of October 2012 to 31 st December 2013) and enrolled all newly diagnosed cases during two calendar years (2011-2012 inclusive). The fate of each and every case was ascertained chronologically during and at the end of the 12 months after diagnosis. Results: The results showed that, of the 352 cases followed up, 102 (29.0%) completed their treatment courses at the end of 1 st year while 105 (29.8 %) of them were still continuing on treatment , 19 (5.4%) relapsed and still on treatment and 89 (25.3 %) of the cases died by the end of first year. The remaining have stopped treatment 25 (7.1%), refused treatment in Basrah 10 (2.8%) or transferred elsewhere on medical advice 2 (0.6%). The one year survival rate for all the studied children was 74.7%, Thus the one year mortality was 25.3%). Among a set of variables, three "female gender, better mother education and modern type of family accommodation" were significant predictors of one year survival of a child with cancer. Conclusions: Childhood cancer is major health problem in Basrah in terms of incidence and burden on the health care system. Despite all efforts the one year survival rate was much lower than corresponding figures in many other countries.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.